Cell Signaling Technology

Product Pathways - Growth Factors/Cytokines

Human Latent Transforming Growth Factor β1 (hLatent TGF-β1) #5154

Latency-associated peptide   TGF-B1 + LAP  

No. Size Price
5154LC 10 µg ( With Carrier ) ¥2,644.00 现货查询 购买询价 防伪查询
5154LF 10 µg ( Carrier Free ) ¥2,644.00 现货查询 购买询价 防伪查询
5154 carrier free & custom formulation / quantityemail request
Applications Dilution Species-Reactivity Sensitivity MW (kDa) Isotype

Species cross-reactivity is determined by western blot.

Applications Key:

Source / Purification

Recombinant human latent TGF-β1 (hLatent TGF-β1) Leu30-Ser390 (Accession #P01137) was expressed in human 293 cells at Cell Signaling Technology.

Cell Signaling Technology使用人293T细胞表达重组人latent TGF-β1 (hLatent TGF-β1) Leu30-Ser390 (Accession #P01137)。

Molecular Characterization

Recombinant hLatent TGF-β1 contains no "tags" and the nonglycosylated small latent TGF-β1 complex has a calculated MW of 41,251. DTT-reduced protein migrates as 40 and 13 kDa polypeptides, and the non-reduced cystine-linked homodimers migrate as 80 and 25 kDa proteins. The expected amino-terminal ALDTN of recombinant hTGF-β1 and the expected amino-terminal LSTSK of recombinant latency-associated peptide (LAP) were verified by amino acid sequencing.

重组hLatent TGF-β1没有标签,计算得到非糖基化的小潜在TGF-β1复合物分子量为41,251。DTT-还原蛋白迁移率显示其包含两条多肽分别为40和13kDa,非还原状态以半胱氨酸连接形成的同二聚体显示蛋白分别为80和25kDa。重组hTGF-β1氨基端序列ALDTN和重组LAP氨基端序列LSTSK通过氨基酸测序确认。


>98% as determined by SDS-PAGE of 6 μg reduced (+) and non-reduced (-) recombinant hLatent TGF-β1. All lots are greater than 98% pure.还原和未还原的mEGF由SDS-PAGE测定纯度大于98%。所有批次的产品纯度均大于98%。


The bioactivity of recombinant hLatent TGF-β1 was determined by assessing inhibition of IL-4 induced HT-2 cell proliferation. The ED50 of each lot is between 4-10 ng/ml and 0.2-0.8 ng/ml after acid activation.

通过抑制IL-4诱导HT-2细胞增殖的实验,以检测重组蛋白hLatent TGF-β1的生物活性。各批次产品经酸激活后ED50在4-10 ng/ml 和 0.2-0.8 ng/ml之间。

Coomassie Gel

Coomassie Gel

The purity of recombinant hLatent TGF-β1 was determined by SDS-PAGE of 6 µg reduced (+) and non-reduced (-) recombinant hLatent TGF-β1 and staining overnight with Coomassie Blue.重组人hLatent TGF-β1 的纯度使用SDS-PAGE确认,6 ug还原(+)和未还原(-)的重组hLatent TGF-β1 电泳后使用考马斯蓝染色过夜。

Western Blotting

Western Blotting

Western blot analysis of extracts from HeLa cells, untreated or treated with the hLatent TGF-β1 for 25 minutes, using Phospho-Smad2 (Ser465/467) (138D4) Rabbit mAb #3108 (upper) and Smad2 (86F7) Rabbit mAb #3122 (lower).使用人hLatent TGF-β1处理25分钟或不处理的HeLa细胞提取物进行Western blot实验,用Phospho-Smad2 (Ser465/467) (138D4) 兔源单克隆抗体#3108 (上)和Smad2(86F7)兔源单克隆抗体#3122(下)进行检测。



The inhibition of IL-4 induced proliferation in HT-2 cells treated with increasing concentrations of hLatent TGF-β1 or acid-activated hLatent TGF-β1 was assessed. After 48 hour treatment with hLatent TGF-β1, cells were incubated with a chemiluminescent cell viability reagent and the relative light units (RLU) were determined.逐渐增长浓度的 hLatent TGF-β1 或酸激活的 hLatent TGF-β1 抑制IL-4 诱导的HT-2细胞的增殖的能力通过实验验证。hLatent TGF-β1处理48小时候,使用一种化学荧光活性试剂抚育细胞,随后检测相对光量(RLU)。


Less than 0.01 ng endotoxin/1 μg hLatent TGF-β1.每1ug hLatent TGF-β1所含内毒素低于0.01ng。


With carrier: A 0.22 μm filtered solution of 0.25 mg/ml hLatent TGF-β1 in PBS, pH 7.2 and 25% (v/v) glycerol containing 20 μg BSA per 1 μg hLatent TGF-β1. Carrier free: A 0.22 μm filtered solution of 0.25 mg/ml hLatent TGF-β1 in PBS, pH 7.2 and 25% (v/v) glycerol.带载体: 0.25 mg/ml hLatent TGF-β1溶于pH 7.2,25% (v/v) glycerol 的PBS溶液使1 μg hLatent TGF-β1携带20 μg BSA,溶液经0.22um滤器过滤获得。无载体:0.25 mg/ml hLatent TGF-β1溶于含有25% (v/v) glycerol pH 7.2 的PBS溶液经0.22um滤器过滤获得。


Latent TGF-β1 is a complex of two proteins, latency associated protein (LAP) and TGF-β1, which is derived from cleavage of a common 75 kDa precursor protein (1). The LAP protein spatially and temporally regulates TGF-β1 activity by sequestering TGF-β1 in the extracellular matrix in conjunction with latent TGF-β1 binding proteins (LTBP)(1). The release of TGF-β1 is activated by a number of stimuli including proteases, thrombospondin-1, reactive oxygen species, and some integrins (1). Active TGF-β1 binds to TβRII homodimer, which then complexes with TβRI homodimer (2,3). The oligomeric receptor complex phosphorylates subsets of the Smad proteins that then act to induce or repress a number of target genes (3-5). TGF-β1 binding can also activate the Erk2, p38, and Jnk pathways via TAK1 (5). Active TGF-β1 activities include proliferation, angiogenesis, and promotion or inhibition of many immune events (2,4,5). Latent TGF-β1 is present on the surface of regulatory T cells in association with GARP and may contribute directly to their immunosuppressive activity (6,7).

潜伏的TGF-β1是两个蛋白组成的复合物,潜伏相关蛋白(LAP)和TGF-β1,TGF-β1由一个75 kDa的前体蛋白的剪切后得到(1)。LAP蛋白可以时空特异性的调控TGF-β1,它促进TGF-β1蛋白与潜在TGF-β1结合蛋白(LTBP)结合,使其留在细胞外基质中(1)。一系列的刺激包括蛋白酶,凝血酶敏感蛋白1,活性氧和一些整合素都可以激活TGF-β1的释放(1)。有活性的TGF-β1与TβRII同二聚体结合,随后再与TβRI同二聚体形成复合物(2,3)。这种低聚受体复合物可以磷酸化Smad蛋白以激活或抑制多种靶基因表达(3-5)。TGF-β1的结合也可以通过TAK1激活Erk2, p38, 和Jnk信号通路(5)。有活性的TGF-β1的功能包括增殖,血管生成和促进或抑制许多免疫反应(2,4,5)。潜伏的TGF-β1与GARP关联由调节T细胞呈递至细胞表面,可能与免疫抑制反应直接相关(6,7)。

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.

用户评论 --- 共 0


我要参与评论 :